Related Experiment Video
Updated: Jul 14, 2026

A Simple and Inexpensive Method for Determining Cold Sensitivity and Adaptation in Mice
Published on: March 17, 2015
Characterisation of TRPM8 as a pharmacophore receptor
Matthias Bödding1, Ulrich Wissenbach, Veit Flockerzi
1Experimentelle und Klinische Pharmakologie und Toxikologie, Universität des Saarlandes, D-66421 Homburg, Germany. matthias.boedding@uniklinik-saarland.de
Abstract:
Some proteins of the transient receptor potential (TRP) family form temperature sensitive ion channels. One member of the melastatin (M) group, namely TRPM8 is activated by cold and cooling compounds such as menthol and icilin, and its gene is up-regulated in prostate cancer and other malignancies. Here we characterise the effects of the carboxamides WS-12, CPS-113, CPS-369, the carboxylic acid WS-30 and the phosphine oxide WS-148 by Ca2+ imaging experiments and whole-cell patch-clamp recordings on TRPM8 expressing human embryonic kidney (HEK), lymph node prostate cancer (LNCaP) and dorsal root ganglia (DRG) cells. The cooling compounds introduced in this study, show a dose-dependent and reversible activation of TRPM8 with EC50 values in the nM to low microM range. The carboxamide WS-12 is most potent in activating TRPM8. It is selective, since other TRP proteins are not stimulated at muM concentrations and its efficacy with respect to TRPM8 is similar to the one of icilin. In summary, the compounds described in this study represent new tools to dissect TRPM8 functions and may serve as chemical leads for the development of additional TRPM8 agonists and novel antagonists. Such compounds may be beneficial for preventing noxious cold perception. They could also be useful in diagnosis and treatment of most common cancers in which the TRPM8 gene is up-regulated in comparison to the corresponding normal tissue.
Insights
New compounds activate the TRPM8 ion channel, which is linked to cancer. These TRPM8 agonists offer potential for pain relief and cancer treatment development.
Area of Science:
- Molecular Biology
- Neuroscience
- Pharmacology
Background:
- Transient Receptor Potential (TRP) channels, including TRPM8, are temperature-sensitive ion channels.
- TRPM8 is activated by cold and cooling agents, and its gene is often overexpressed in prostate cancer and other malignancies.
Purpose of the Study:
- To characterize novel cooling compounds as TRPM8 activators.
- To evaluate the potency, selectivity, and efficacy of these compounds on TRPM8.
- To explore their potential as research tools and therapeutic leads.
Main Methods:
- Calcium (Ca2+) imaging experiments.
- Whole-cell patch-clamp recordings.
- Experiments conducted on TRPM8-expressing human embryonic kidney (HEK), prostate cancer (LNCaP), and dorsal root ganglia (DRG) cells.
Main Results:
- The tested compounds (WS-12, CPS-113, CPS-369, WS-30, WS-148) demonstrated dose-dependent and reversible activation of TRPM8.
- WS-12 was identified as the most potent TRPM8 activator, showing selectivity for TRPM8 over other TRP channels.
- Compound efficacy was comparable to known TRPM8 agonist icilin.
Conclusions:
- The novel carboxamides and other compounds are effective TRPM8 agonists.
- These compounds serve as valuable tools for studying TRPM8 function.
- They represent promising chemical leads for developing new TRPM8-targeting drugs for pain management and cancer therapy.
Related Concept Videos
Thermosensation
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with one...
Opioid Receptors: Overview
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Quantitative Aspects of Drug-Receptor Interaction
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical, 7TM, or...
